-
-
-
-
-
-
-
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
-
-
-
-
-
-
-
Orchard Therapeutics Plc (ORTX) Misses Q3 EPS by 14c
-
-
-
-
-
-
-
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
-
-
-
-
-
-
-
Orchard Therapeutics Extends Runway into 2024, Focusing HSC Gene Therapy Platform Exclusively on Severe Neurometabolic Diseases and Research Platform
-
-
-
-
-
-
-
Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021
-
-
-
-
-
-
-
Cryoport Expands Global Supply Chain Network with Belgium Acquisition
-
-
-
-
-
-
-
Cryoport Reports Record Results for Full Year 2020
-
974,959 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All